Added protection behind the masks : Duke scientists develop nasal, throat spray to battle COVID-19 dukechronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dukechronicle.com Daily Mail and Mail on Sunday newspapers.
Work to develop a new formulation of a common metabolic inhibitor (niclosamide) by David Needham, Professor of Translational Therapeutics in the School of Pharmacy at the University of Nottingham and Professor of Mechanical Engineering and Materials Science at Duke University, could result in a promising early treatment for Covid-19. Click to read more.
Mechanical engineering and materials science professor David Needham has shown that a slight increase in solution pH might be all it takes to turn a metabolic inhibiting drug, traditionally used to treat gut parasites, into a promising prophylactic/preventative nasal spray and early treatment throat spray for COVID-19.